- Home
- ELUT vs RFAI Comparison
ELUT vs RFAI Comparison
Compare ELUT & RFAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELUT
- RFAI
- Stock Information
- Founded
- ELUT 2015
- RFAI 2024
- Country
- ELUT United States
- RFAI Singapore
- Employees
- ELUT 54
- RFAI N/A
- Industry
- ELUT Medical Specialities
- RFAI
- Sector
- ELUT Health Care
- RFAI
- Exchange
- ELUT Nasdaq
- RFAI NYSE
- Market Cap
- ELUT 145.2M
- RFAI 153.0M
- IPO Year
- ELUT 2020
- RFAI 2024
- Fundamental
- Price
- ELUT $4.20
- RFAI $10.18
- Analyst Decision
- ELUT Strong Buy
- RFAI
- Analyst Count
- ELUT 2
- RFAI 0
- Target Price
- ELUT $10.00
- RFAI N/A
- AVG Volume (30 Days)
- ELUT 42.1K
- RFAI 16.5K
- Earning Date
- ELUT 11-14-2024
- RFAI 01-01-0001
- Dividend Yield
- ELUT N/A
- RFAI N/A
- EPS Growth
- ELUT N/A
- RFAI N/A
- EPS
- ELUT N/A
- RFAI N/A
- Revenue
- ELUT $24,782,000.00
- RFAI N/A
- Revenue This Year
- ELUT $8.00
- RFAI N/A
- Revenue Next Year
- ELUT $39.89
- RFAI N/A
- P/E Ratio
- ELUT N/A
- RFAI N/A
- Revenue Growth
- ELUT N/A
- RFAI N/A
- 52 Week Low
- ELUT $1.86
- RFAI $10.00
- 52 Week High
- ELUT $5.24
- RFAI $10.27
- Technical
- Relative Strength Index (RSI)
- ELUT 52.78
- RFAI N/A
- Support Level
- ELUT $3.90
- RFAI N/A
- Resistance Level
- ELUT $4.40
- RFAI N/A
- Average True Range (ATR)
- ELUT 0.39
- RFAI 0.00
- MACD
- ELUT -0.04
- RFAI 0.00
- Stochastic Oscillator
- ELUT 24.59
- RFAI 0.00
About ELUT Elutia Inc.
Elutia Inc Formerly Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. The company's segments include Device Protection, Women's Health and Cardiovascular. It generates maximum revenue from the Women's Health segment. The products of the company are targeted to address unmet clinical needs with the goal of promoting healthy tissue formation and avoiding complications associated with medical device implants, such as scar-tissue formation, capsular contraction, erosion, migration, non-union of implants and implant rejection.
About RFAI RF ACQUISITION CORP II
RF Acquisition Corp II is a blank check company.